🚨 MEI Pharma Announces $100M Litecoin Treasury Strategy
MEI Pharma has become the first publicly traded U.S. 🇺🇲 company to adopt a dedicated Litecoin Treasury Strategy, acquiring 929,548 $LTC valued at approximately $100 million — at an average purchase price of $107.58 per token.
This strategic move, advised by Charlie Lee and GSR, marks a significant milestone in institutional adoption of Litecoin.
